button video small     505(b)(2): An Outlook
on Opportunity

Watch the video

CaseStudyPills 20092780sm

    Ready 4 Action?
Learn how Camargo helps ensure your product is good on all four.

button video small

  Accelerate Your Drug Development With Existing Evidence
Watch the video

 

 

Full-Service
Drug Development
Through The
505(b)(2) Process

    

While its rewards are abundant, the 505(b)(2) process presents unique and demanding requirements — you need the specialists at Camargo to help you identify a differentiated product and guide you from concept through commercialization. With 3-5 pre-IND meetings per month, worldwide reach in 26 countries and a client referral rate of 95 percent, it’s easy to see how success breeds success.

  •   Product planning (Ready 4 Action)
  •   Preclinical
  •   Feasibility assessments
  •   CMC (API, formulation development)

   •   Phase I-IV program development
   •   Proof-of-concept
   •   Pharmacokinetics
   •   Regulatory consulting & submissions

 


blog header

DRUG KENNEL

President's Blog

blog footer